Theratechnologies (Theratechnologies) Total Stockholders Equity : $-24.60 Mil (As of Feb. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Total Stockholders Equity?

Theratechnologies's Total Stockholders Equity for the quarter that ended in Feb. 2024 was $-24.60 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Theratechnologies's Book Value per Share for the quarter that ended in Feb. 2024 was $-0.54. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Theratechnologies's Debt-to-Equity for the quarter that ended in Feb. 2024 was -2.40.

Theratechnologies Total Stockholders Equity Historical Data

The historical data trend for Theratechnologies's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Total Stockholders Equity Chart

Theratechnologies Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Total Stockholders Equity

Get a 7-Day Free Trial

24.83

3.22

17.76

-22.57

-20.87

Theratechnologies Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Total Stockholders Equity	Get a 7-Day Free Trial															-32.31	-41.53	-41.70	-20.87	-24.60

Theratechnologies (NAS:THTX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Theratechnologies's Book Value per Share for the quarter that ended in Feb. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-24.602	-	0)	/	45.98
	=	-0.54

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Theratechnologies's Debt-to-Equity for the quarter that ended in Feb. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(12.785	+	46.355)	/	-24.602
	=	-2.40

Theratechnologies Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies (Theratechnologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

TQ80:Germany TH:Canada

Address

2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8

Website

https://www.theratech.com

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.